600535.SH
Tasly Pharmaceutical Group Co., Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 13.65
−0.36%Leverage
- Debt / equity
- 0.08x
- Net debt / equity
- 0.03x
- Debt / assets
- 0.07x
- Debt / EBITDA
- 0.59x
- Net debt / EBITDA
- 0.24x
Liquidity & coverage
- Current ratio
- 3.72x
- Quick ratio
- 3.09x
- Cash ratio
- —
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- CNY 6.3B
Cash & dividend
- FCF / debt
- 1.85x
- Cash flow / debt
- 2.10x
- Dividend per share
- CNY 0.34
- Dividend yield
- 2.5%
- Dividend growth 1y
- -37.9%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Mar 1, 2026